Sai Parenteral's Ltd.
•2026-08-21
PROS
CONS
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.35x)
- Operating cash flow has been negative in recent years
- Inventory has been piling up - inventory days up from 60 to 99
- Though reporting repeated profits, the company pays out little dividend (0.0%)
- Debtor days have increased from 223 to 284
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SAIPARENT | 540.25 | 167.39 | 2386.78 | 0.00 | 79.23 | — | 1786.72 | — | 7.03 | 13.16 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| 33 | 198 | 179 | |
| 33 | 172 | 173 | |
| Operating Profit | — | — | — |
| OPM % | — | — | — |
| Other Income | 1 | 3 | 4 |
| Interest | 2 | 8 | 9 |
| Depreciation | 1 | 8 | 8 |
| 2 | 12 | 10 | |
| Tax % | 29.43% | -6.13% | 19.07% |
| Net Profit | 1 | 13 | 8 |
| 0 | 4 | 0 | |
| Equity Capital | 13 | 22 | 22 |
| Reserves | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% |
| Equity Capital | 13 | 22 | 22 |
| Reserves | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% |
- 33
- 33
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 1
- 2
- Tax %
- 29.43%
- Net Profit
- 1
- 0
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 198
- 172
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 8
- Depreciation
- 8
- 12
- Tax %
- -6.13%
- Net Profit
- 13
- 4
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 179
- 173
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 9
- Depreciation
- 8
- 10
- Tax %
- 19.07%
- Net Profit
- 8
- 0
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 97 | 154 | 163 | |
| 78 | 122 | 124 | |
| Operating Profit | 19 | 33 | 40 |
| OPM % | 19 | 22 | 25 |
| Other Income | 0 | 2 | 1 |
| Interest | 6 | 11 | 12 |
| Depreciation | 6 | 9 | 8 |
| 7 | 13 | 20 | |
| Tax % | 40 | 33 | 28 |
| Net Profit | 4 | 8 | 14 |
| EPS | 6 | 7 | 5 |
| Dividend Payout % | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | -0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 3 | 3 | 5 |
| Minority Interest | 0 | 0 | -0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 3 | 3 | 5 |
- 97
- 78
- Operating Profit
- 19
- OPM %
- 19
- Other Income
- 0
- Interest
- 6
- Depreciation
- 6
- 7
- Tax %
- 40
- Net Profit
- 4
- EPS
- 6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- 154
- 122
- Operating Profit
- 33
- OPM %
- 22
- Other Income
- 2
- Interest
- 11
- Depreciation
- 9
- 13
- Tax %
- 33
- Net Profit
- 8
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- 163
- 124
- Operating Profit
- 40
- OPM %
- 25
- Other Income
- 1
- Interest
- 12
- Depreciation
- 8
- 20
- Tax %
- 28
- Net Profit
- 14
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 5
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 16%
- Last Year:
- 17%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 7 | 13 | 13 |
| 24 | 61 | 80 | |
| 43 | 71 | 73 | |
| Trade Payables | 22 | 53 | 58 |
| 37 | 69 | 47 | |
| Total Liabilities | 134 | 267 | 272 |
| ASSETS | - | - | - |
| 44 | 70 | 53 | |
| Capital Work in Progress | 2 | 0 | 0 |
| 13 | 37 | 51 | |
| 0 | 127 | 127 | |
| Cash & Bank | 0 | 4 | 2 |
| 75 | 29 | 38 | |
| Total Assets | 134 | 267 | 272 |
| Total Debt | 69 | 119 | 94 |
| Net Working Capital | 5 | 35 | 38 |
| Contingent Liabilities | 2 | 4 | 2 |
| Book Value per Share | 44.03 | 56.27 | 35.19 |
| Face Value | 10.00 | 10.00 | 5.00 |
| Total Debt | 69 | 119 | 94 |
| Net Working Capital | 5 | 35 | 38 |
| Contingent Liabilities | 2 | 4 | 2 |
| Book Value per Share | 44.03 | 56.27 | 35.19 |
| Face Value | 10.00 | 10.00 | 5.00 |
- Equity Capital
- 7
- 24
- 43
- Trade Payables
- 22
- 37
- Total Liabilities
- 134
- 44
- Capital Work in Progress
- 2
- 13
- 0
- Cash & Bank
- 0
- 75
- Total Assets
- 134
- Total Debt
- 69
- Net Working Capital
- 5
- Contingent Liabilities
- 2
- Book Value per Share
- 44.03
- Face Value
- 10.00
- Total Debt
- 69
- Net Working Capital
- 5
- Contingent Liabilities
- 2
- Book Value per Share
- 44.03
- Face Value
- 10.00
- Equity Capital
- 13
- 61
- 71
- Trade Payables
- 53
- 69
- Total Liabilities
- 267
- 70
- Capital Work in Progress
- 0
- 37
- 127
- Cash & Bank
- 4
- 29
- Total Assets
- 267
- Total Debt
- 119
- Net Working Capital
- 35
- Contingent Liabilities
- 4
- Book Value per Share
- 56.27
- Face Value
- 10.00
- Total Debt
- 119
- Net Working Capital
- 35
- Contingent Liabilities
- 4
- Book Value per Share
- 56.27
- Face Value
- 10.00
- Equity Capital
- 13
- 80
- 73
- Trade Payables
- 58
- 47
- Total Liabilities
- 272
- 53
- Capital Work in Progress
- 0
- 51
- 127
- Cash & Bank
- 2
- 38
- Total Assets
- 272
- Total Debt
- 94
- Net Working Capital
- 38
- Contingent Liabilities
- 2
- Book Value per Share
- 35.19
- Face Value
- 5.00
- Total Debt
- 94
- Net Working Capital
- 38
- Contingent Liabilities
- 2
- Book Value per Share
- 35.19
- Face Value
- 5.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -13 | -30 | 33 | |
| Cash from Investing | -19 | -46 | 0 |
| Cash from Financing | 24 | 79 | -36 |
| -8 | 2 | -2 | |
| Free Cash Flow | -13 | -72 | 33 |
| OCF / Net Profit | -2.92 | -3.54 | 2.30 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | -2.92 | -3.54 | 2.30 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
- -13
- Cash from Investing
- -19
- Cash from Financing
- 24
- -8
- Free Cash Flow
- -13
- OCF / Net Profit
- -2.92
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -2.92
- Cumulative 5-Year FCF
- 0
- -30
- Cash from Investing
- -46
- Cash from Financing
- 79
- 2
- Free Cash Flow
- -72
- OCF / Net Profit
- -3.54
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -3.54
- Cumulative 5-Year FCF
- 0
- 33
- Cash from Investing
- 0
- Cash from Financing
- -36
- -2
- Free Cash Flow
- 33
- OCF / Net Profit
- 2.30
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.30
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 6.12 | 6.71 | 5.33 |
| Book Value (₹) | 44.03 | 56.27 | 35.19 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 7.11 | 6.73 | 8.50 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 19.39% | 20.54% | 24.15% |
| Net Margin % | 4.52% | 5.47% | 8.85% |
| ROE % | 13.90% | 15.87% | 17.15% |
| ROCE % | 12.97% | 16.14% | 16.70% |
| 3.27% | 4.19% | 5.35% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 231 | 223 | 284 |
| Inventory Days | 50 | 60 | 99 |
| Payable Days | 140 | 144 | 215 |
| 140 | 139 | 167 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 2.18x | 1.59x | 1.00x |
| Interest Coverage (x) | 2.27x | 2.13x | 2.67x |
| 1.07x | 1.23x | 1.23x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 58.85% | 6.08% |
| Operating Profit Growth % | 0.00% | 76.34% | 20.93% |
| Net Profit Growth % | 0.00% | 92.30% | 71.44% |
| 0.00% | 9.60% | -20.46% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 3.86x | 2.63x |
- EPS (₹)
- 6.12
- Book Value (₹)
- 44.03
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.11
- Operating Margin %
- 19.39%
- Net Margin %
- 4.52%
- ROE %
- 13.90%
- ROCE %
- 12.97%
- 3.27%
- Debtor Days
- 231
- Inventory Days
- 50
- Payable Days
- 140
- 140
- Debt to Equity (x)
- 2.18x
- Interest Coverage (x)
- 2.27x
- 1.07x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
- EPS (₹)
- 6.71
- Book Value (₹)
- 56.27
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.73
- Operating Margin %
- 20.54%
- Net Margin %
- 5.47%
- ROE %
- 15.87%
- ROCE %
- 16.14%
- 4.19%
- Debtor Days
- 223
- Inventory Days
- 60
- Payable Days
- 144
- 139
- Debt to Equity (x)
- 1.59x
- Interest Coverage (x)
- 2.13x
- 1.23x
- Revenue Growth %
- 58.85%
- Operating Profit Growth %
- 76.34%
- Net Profit Growth %
- 92.30%
- 9.60%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.86x
- EPS (₹)
- 5.33
- Book Value (₹)
- 35.19
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.50
- Operating Margin %
- 24.15%
- Net Margin %
- 8.85%
- ROE %
- 17.15%
- ROCE %
- 16.70%
- 5.35%
- Debtor Days
- 284
- Inventory Days
- 99
- Payable Days
- 215
- 167
- Debt to Equity (x)
- 1.00x
- Interest Coverage (x)
- 2.67x
- 1.23x
- Revenue Growth %
- 6.08%
- Operating Profit Growth %
- 20.93%
- Net Profit Growth %
- 71.44%
- -20.46%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 2.63x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-20 - Intimation-Newspaper Publication of Notice of 25" Annual General Meeting of the Company for the financial year 2025-26.
- Copy of Newspaper Publication
2026-08-20 - Submission of Newspaper Publication(s) in PAS-1 for change and variation in the objects of utilization of the Initial Public Offering ( IPO ) proceeds
Annual Reports
Nothing filed yet.
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026

